Role of coronary computed tomography angiography to optimise percutaneous coronary intervention outcomes.
Published in Heart (British Cardiac Society)
Published in Heart (British Cardiac Society)
Published in Heart (British Cardiac Society)
Published in Heart (British Cardiac Society)
Published in Heart (British Cardiac Society)
Published in Heart (British Cardiac Society)
Valvular heart disease, including calcific or degenerative aortic stenosis (AS), is increasingly prevalent among the older adult population. Over the last few decades, treatment of severe AS has been revolutionised following the development of transcatheter aortic valve replacement (TAVR). Despite improvements in outcomes, older adults with competi...
Published in Heart (British Cardiac Society)
To investigate the incidence and mortality risk associated with postdischarge major bleeding after coronary artery bypass grafting (CABG), and relate this to the incidence of, and mortality risk from, postdischarge myocardial infarction. All patients undergoing first-time isolated CABG in Sweden in 2006-2017 and surviving 14 days after hospital dis...
Published in Heart (British Cardiac Society)
Published in Heart (British Cardiac Society)
Assessment of generalisability of guideline-informing trials on antithrombotic treatment intensification to real-world patients with cardiovascular disease (CVD). Inclusion and exclusion criteria of the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS), Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilizatio...
Published in Heart (British Cardiac Society)
Guidelines are more accessible than ever and represent an important tool in clinical practice. The National Institute for Health and Care Excellence (NICE) has developed recommendations for heart failure diagnosis and management based not only on morbidity and mortality trial outcome data but also in-depth economic analysis, with a focus on general...
Published in Heart (British Cardiac Society)
This study aimed to explore the prognostic impact of cognitive impairment on the long-term risk of major adverse cardiovascular events (MACEs) in older patients with non-ST-elevation acute coronary syndrome (NSTEACS) undergoing invasive treatment. Patients aged ≥75 years with NSTEACS undergoing an invasive strategy were included in the multicentre ...